Prolysis is an antibacterial drug discovery and development company, focused on the development of new classes of DNA supercoiling and cell division inhibitors to treat hospital-acquired and community-associated infections.

Oaktree were approached to provide a solution for a new laboratory area, including ceiling, flooring and partition works.

A quick turnaround on decision making was required and this was achieved. From initial site survey to signed order was less than 3 days.

More information to follow

For further information on Prolysis, please click here:

www.prolysis.com